blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3046938

EP3046938 - BI- OR MULTISPECIFIC POLYPEPTIDES BINDING IMMUNE EFFECTOR CELL SURFACE ANTIGENS AND HBV ANTIGENS FOR TREATING HBV INFECTIONS AND ASSOCIATED CONDITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.10.2020
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  01.11.2019
FormerGrant of patent is intended
Status updated on  30.07.2019
FormerExamination is in progress
Status updated on  30.06.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstrasse 1
85764 Neuherberg / DE
For all designated states
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg / DE
[2016/30]
Inventor(s)01 / PROTZER, Ulrike
Anzlgutstr. 45
81735 München / DE
02 / BOHNE, Felix
Wildrosenweg 58
81929 München / DE
03 / MOMBURG, Frank
Bachstr. 37
69121 Heidelberg / DE
04 / MOLDENHAUER, Gerhard
Jahnstr. 11
34454 Bad Arolsen / DE
 [2019/49]
Former [2016/30]01 / PROTZER, Ulrike
Anzlgutstr. 45
81735 München / DE
02 / BOHNE, Felix
Wildrosenweg 58
81929 München / DE
03 / MOMBURG, Frank
Bachstr. 37
69121 Heidelberg / DE
04 / MOLDENHAUER, Gerhard
Keplerstr. 22
69120 Heidelberg / DE
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2016/30]
Application number, filing date14771250.916.09.2014
[2016/30]
WO2014EP69675
Priority number, dateEP2013018463516.09.2013         Original published format: EP 13184635
[2016/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015036606
Date:19.03.2015
Language:EN
[2015/11]
Type: A1 Application with search report 
No.:EP3046938
Date:27.07.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 19.03.2015 takes the place of the publication of the European patent application.
[2016/30]
Type: B1 Patent specification 
No.:EP3046938
Date:04.12.2019
Language:EN
[2019/49]
Search report(s)International search report - published on:EP19.03.2015
ClassificationIPC:C07K16/08, C07K16/28, C07K16/46, A61K39/395, A61P31/20
[2016/30]
CPC:
C07K16/2809 (EP,RU,US); C07K16/082 (EP,RU,US); A61K2239/31 (EP,RU,US);
A61K2239/38 (EP,RU,US); A61K2239/53 (EP,RU,US); A61K39/461 (EP,RU,US);
A61K39/464838 (EP,RU,US); A61P1/16 (EP); A61P31/20 (EP);
A61P37/04 (EP); C07K16/2803 (EP,US); C07K16/2818 (EP,RU,US);
C07K16/283 (EP,RU,US); C12N5/0638 (EP,RU,US); C12N5/0646 (EP,RU,US);
A61K2039/505 (EP,US); A61K2039/507 (EP,US); C07K2317/14 (US);
C07K2317/31 (EP,US); C07K2317/35 (EP,US); C07K2317/52 (EP,US);
C07K2317/524 (US); C07K2317/526 (US); C07K2317/565 (US);
C07K2317/622 (EP,US); C07K2317/73 (EP,US); C07K2317/732 (EP,US);
C07K2319/00 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/30]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:BI- ODER MULTISPEZIFISCHE POLYPEPTIDE WELCHE AN OBERFLÄCHENANTIGENE VON IMMUNEFFEKTORZELLEN UND AN HBV ANTIGENE BINDEN ZUR BEHANDLUNG VON HBV-INFEKTIONEN UND VERWANDTEN ERKRANKUNGEN[2019/31]
English:BI- OR MULTISPECIFIC POLYPEPTIDES BINDING IMMUNE EFFECTOR CELL SURFACE ANTIGENS AND HBV ANTIGENS FOR TREATING HBV INFECTIONS AND ASSOCIATED CONDITIONS[2016/30]
French:POLYPEPTIDES BI- OU MULTISPÉCIFIQUES SE LIANT AUX ANTIGÈNES DE SURFACE DES CELLULES EFFECTRICES IMMUNES ET AUX ANTIGÈNES DE HBV POUR LE TRAITEMENT DE L'INFECTION HBV ET CONDITIONS ASSOCIÉES[2019/31]
Former [2016/30]BI-ODER MULTISPEZIFISCHE POLYPEPTIDE ZUR BINDUNG VON IMMUNEFFEKTOR-ZELLOBERFLÄCHEN-ANTIGENEN UND HBV-ANTIGENEN ZUR BEHANDLUNG VON HBV-INFEKTIONEN UND VERWANDTEN ERKRANKUNGEN
Former [2016/30]POLYPEPTIDES BISPÉCIFIQUES OU MULTISPÉCIFIQUES SE LIANT À DES ANTIGÈNES DE SURFACE DE CELLULE EFFECTRICE IMMUNITAIRE ET ANTIGÈNES DU VHB POUR TRAITER LES INFECTIONS PAR LE VIRUS DE L'HÉPATITE B ET ÉTATS ASSOCIÉS
Entry into regional phase31.03.2016National basic fee paid 
31.03.2016Designation fee(s) paid 
31.03.2016Examination fee paid 
Examination procedure17.03.2016Amendment by applicant (claims and/or description)
31.03.2016Examination requested  [2016/30]
29.06.2017Despatch of a communication from the examining division (Time limit: M04)
19.10.2017Reply to a communication from the examining division
09.03.2018Despatch of a communication from the examining division (Time limit: M04)
11.04.2018Reply to a communication from the examining division
24.06.2019Cancellation of oral proceeding that was planned for 25.06.2019
25.06.2019Date of oral proceedings (cancelled)
31.07.2019Communication of intention to grant the patent
22.10.2019Fee for grant paid
22.10.2019Fee for publishing/printing paid
22.10.2019Receipt of the translation of the claim(s)
Opposition(s)07.09.2020No opposition filed within time limit [2020/46]
Fees paidRenewal fee
23.09.2016Renewal fee patent year 03
22.09.2017Renewal fee patent year 04
24.09.2018Renewal fee patent year 05
24.09.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.09.2014
AL04.12.2019
CY04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
MC04.12.2019
MK04.12.2019
MT04.12.2019
NL04.12.2019
PL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
TR04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
[2022/32]
Former [2022/27]HU16.09.2014
AL04.12.2019
CY04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
MC04.12.2019
MT04.12.2019
NL04.12.2019
PL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
TR04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2021/23]AL04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
MC04.12.2019
NL04.12.2019
PL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/51]AL04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
NL04.12.2019
PL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/47]AL04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
NL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/40]AL04.12.2019
CZ04.12.2019
EE04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
NL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/37]AL04.12.2019
CZ04.12.2019
EE04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
NL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
PT29.04.2020
Former [2020/36]AL04.12.2019
CZ04.12.2019
EE04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
NL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
PT29.04.2020
Former [2020/35]AL04.12.2019
CZ04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
NL04.12.2019
RO04.12.2019
RS04.12.2019
SE04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/32]AL04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
NL04.12.2019
RS04.12.2019
SE04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/26]FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RS04.12.2019
SE04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/23]FI04.12.2019
LT04.12.2019
LV04.12.2019
SE04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/22]FI04.12.2019
LT04.12.2019
SE04.12.2019
BG04.03.2020
NO04.03.2020
Former [2020/21]NO04.03.2020
Cited inInternational search[I]EP2524699  (TRION RES GMBH [DE]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.